The first and only source to offer an all-encompassing approach to the pathogenesis and treatment of thrombocytopenic disorders, this book reviews current information concerning thrombocytopenia due to diminished platelet production and accelerated immunologic and nonimmunologic platelet clearance, as well as a detailed review of medications that cause this disorder.
מה אומרים אנשים - כתיבת ביקורת
לא מצאנו ביקורות במקומות הרגילים
Biology and Potential Clinical
Congenital Inherited Familial
6 קטעים אחרים שאינם מוצגים
מהדורות אחרות - הצג הכל
activation acute addition adults agents alloimmune anemia antibodies antigen appears assay associated autoantibodies autoimmune binding bleeding Blood bone marrow cause cells chemotherapy chronic circulating Clin clinical common complex complications considered deficiency described detection diagnosis disease disorders donor dose drug effect et al evidence expression factor fetal function gene given glycoprotein growth Haematol hematopoietic hemorrhage heparin heparin-induced thrombocytopenia human idiopathic thrombocytopenic purpura immune immune thrombocytopenic important increased individuals induced infection initial intravenous involved less leukemia levels maternal mechanisms megakaryocyte mice mutation neonatal normal observed occur patients plasma platelet count platelet production platelet transfusions pregnancy present protein reactions recent receptor recognized recombinant reduced refractory renal reported response risk role severe severe thrombocytopenia shown specific splenectomy stem cell studies suggest syndrome Table testing therapy thrombin thrombopoietin thrombosis transplantation treated treatment trial usually Warkentin